Influx Healthtech Limited

INFLUX NSE Healthcare Pharmaceuticals

Strengths

  • Net profit margin is 14.3%.
  • Promoters hold a majority stake (73.53%).

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 627 Cr
Current Price
High / Low₹ 315.00 / 161.00
Stock P/E30.50
Book Value
Dividend Yield0.00%
ROCE
ROE
Face Value₹ 10.00
Debt to Equity
PEG Ratio
EV / EBITDA18.44
Industry PE35.70
P/B Ratio
EPS₹ 8.87
Debt
PAT Margin14.29%
Cash PAT₹ 25 Cr
ICR
Promoter Holding73.53%
FII Holding0.16%
DII Holding5.65%
Public Holding20.66%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Educational data only. Not a recommendation to buy, sell or hold any security.